Literature DB >> 16344063

Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.

Carlos Terra1, Mónica Guevara, Aldo Torre, Rosa Gilabert, Javier Fernández, Marta Martín-Llahí, Maria E Baccaro, Miquel Navasa, Conxita Bru, Vicente Arroyo, Juan Rodés, Pere Ginès.   

Abstract

BACKGROUND & AIMS: Although renal failure is a common complication of sepsis and patients with cirrhosis frequently develop sepsis, there have been no studies specifically assessing renal function in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis. The aim of this study was to investigate prospectively the frequency, characteristics, and outcome of renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis.
METHODS: One hundred six consecutive patients with cirrhosis and sepsis were studied prospectively. Patients with spontaneous bacterial peritonitis were excluded.
RESULTS: Twenty-nine out of 106 patients (27%) with cirrhosis and sepsis developed acute renal failure as compared with only 8 of 100 patients (8%) from a control group of cirrhotic patients without infection (P < .0001). Renal failure in the sepsis group was reversible in 22 (76%; 21% of all patients) patients and nonreversible in 7 (24%; 6% of all patients) patients. Renal failure was associated with impairment of effective arterial blood volume, without evidence of tubular damage. The occurrence and type of renal failure correlated strongly with mortality (mortality at 3 months: nonreversible renal failure, 100%; reversible renal failure, 55%; no renal failure, 13%). Among variables obtained at diagnosis of sepsis, the Model for End-Stage Liver Disease (MELD) score was the only independent predictive factor of mortality.
CONCLUSIONS: Renal failure is common in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis and is associated with arterial underfilling and renal vasoconstriction. Outcome is poor, even in the setting of reversible renal failure. The MELD score is the best prognostic marker of patients with cirrhosis and sepsis.

Entities:  

Mesh:

Year:  2005        PMID: 16344063     DOI: 10.1053/j.gastro.2005.09.024

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  45 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

3.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

4.  New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Authors:  Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

Review 5.  Renal impairment in cirrhosis unrelated to hepatorenal syndrome.

Authors:  Gavin Low; Graeme Jm Alexander; David J Lomas
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

Review 6.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

7.  Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.

Authors:  Kenneth Berman; Sweta Tandra; Kate Forssell; Raj Vuppalanchi; Raj Vuppalanch; James R Burton; James Nguyen; Devonne Mullis; Paul Kwo; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-17       Impact factor: 11.382

8.  Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites.

Authors:  Gavin Low; Nicola E Owen; Ilse Joubert; Andrew J Patterson; Martin J Graves; Graeme J M Alexander; David J Lomas
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

9.  Renal Dysfunction Induced by Bacterial Infection other than Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: Incidence and Risk Factor.

Authors:  Jong Hoon Kim; June Sung Lee; Seuk Hyun Lee; Won Ki Bae; Nam-Hoon Kim; Kyung-Ah Kim; Young-Soo Moon
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

10.  Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis.

Authors:  Hong Zang; Fangfang Liu; Hongling Liu; Shaoli You; Bing Zhu; Zhihong Wan; Shaojie Xin
Journal:  Hepatol Int       Date:  2016-08-02       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.